250 related articles for article (PubMed ID: 11392726)
1. Genetic medicine. Powerful opportunities for good and greed.
Dalzell MD
Manag Care; 2001 May; 10(5):22-3, 27-8, 33-7. PubMed ID: 11392726
[No Abstract] [Full Text] [Related]
2. Perspectives. Will genome science shift clinical, insurance paradigms?
Clemmitt M
Med Health; 2000 Sep; 54(37):suppl 1-4. PubMed ID: 11184793
[No Abstract] [Full Text] [Related]
3. Genetic testing, genetic medicine, and managed care.
Rothstein MA; Hoffman S
Wake Forest Law Rev; 1999; 34(3):849-88. PubMed ID: 12664926
[TBL] [Abstract][Full Text] [Related]
4. Genomics in medicine: hype or real promise? Interview by Ed Rabinowitz.
Jones S; Collins F
Healthplan; 2003; 44(1):20-4. PubMed ID: 12611249
[No Abstract] [Full Text] [Related]
5. Applying advances in genetic medicine: where do we go from here?
Billings PR
Healthplan; 2000; 41(6):32-5. PubMed ID: 11185807
[No Abstract] [Full Text] [Related]
6. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
Mackler BF; Barach M
J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
[TBL] [Abstract][Full Text] [Related]
7. The dream of the human genome: doubts about the Human Genome Project.
Lewontin R
New York Rev Books; 1992 May; 39(10):31-40. PubMed ID: 11659413
[No Abstract] [Full Text] [Related]
8. Genetics, ethics, and human values: human genome mapping, genetic screening and gene therapy.
Miller J
NCBHR Commun; 1990; 1(1):11-3. PubMed ID: 11660184
[No Abstract] [Full Text] [Related]
9. Icelandic biotech feels the pinch.
Wadman M
Nature; 2008 Oct; 455(7215):842. PubMed ID: 18938257
[No Abstract] [Full Text] [Related]
10. Shaping priorities in genetic medicine.
Boyle PJ
Hastings Cent Rep; 1995; 25(3 Suppl):S2-8. PubMed ID: 11654187
[TBL] [Abstract][Full Text] [Related]
11. Ethical problems in biological research in medicine.
Serra A
Dolentium Hominum; 1995; 10(1):130-7. PubMed ID: 15839017
[No Abstract] [Full Text] [Related]
12. Genetic medicine in the next five years.
Guttmacher AE
Health Prog; 1999; 80(5):43-5, 48. PubMed ID: 10623181
[No Abstract] [Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. Commercial molecular diagnostics in the U.S.: The Human Genome Project to the clinical laboratory.
Amos J; Patnaik M
Hum Mutat; 2002 Apr; 19(4):324-33. PubMed ID: 11933187
[TBL] [Abstract][Full Text] [Related]
15. An overview of education and 'new genetics'.
Terry L; Cedar SH
Nurs Stand; 2001 Mar 28-Apr 3; 15(28):38-40. PubMed ID: 12216253
[TBL] [Abstract][Full Text] [Related]
16. The impact of managed care on genetic testing laboratories in the United States.
Mark HF; Prence E; Beauregard L; Greenstein R
Cytobios; 1996; 88(352):43-52. PubMed ID: 9243821
[TBL] [Abstract][Full Text] [Related]
17. Managed care and efficient rationing.
Rosenthal MB; Newhouse JP
J Health Care Finance; 2002; 28(4):1-10. PubMed ID: 12148660
[TBL] [Abstract][Full Text] [Related]
18. Designing and implementing an effective specialty pharmacy service program.
Morrow TJ
Manag Care Interface; 2003 Apr; 16(4):50-3. PubMed ID: 12747141
[TBL] [Abstract][Full Text] [Related]
19. Task force 3: clinical research in a molecular era and the need to expand its ethical imperatives.
Roberts R; Ryan TJ
J Am Coll Cardiol; 1998 Apr; 31(5):942-9. PubMed ID: 9561991
[No Abstract] [Full Text] [Related]
20. Mapping morality: ethics and the Human Genome Project. An interview with Arthur L. Caplan, Ph.D.
McIntyre RL; Caplan AL
Trends Health Care Law Ethics; 1994; 9(3):7-12, 32. PubMed ID: 11652977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
